Injection Treatment of Cartilage Injury

Novartis Pharmaceuticals is sponsoring a clinical research trial for males and females, ages 18-55 years, with a cartilage injury of partial thickness of one knee. To learn more about knee joint cartilage injuries, click here. This study is designed to assess the efficacy, safety, and  tolerability of multiple injections of the study drug (or placebo) over [...]

GelrinC by Regentis Biomaterials for Cartilage Repair

Regentis Biomaterials is conducting a pivotal FDA regulated clinical study (research study) to evaluate the safety and efficacy of an investigational device, GelrinC, implanted following a standard microfracture procedure, compared to a historical control group of patients who have undergone microfracture for the treatment of articular cartilage defects of the knee. This is a non-randomized [...]

Go to Top